A method for establishing class III medical device equivalence: sodium hyaluronate (GenVisc 850) for the treatment of knee osteoarthritis

References

• United States Government Publishing OfficePublic Law 98-417 – September 24, 19841984 Available from: https://www.gpo.gov/fdsys/pkg/STATUTE-98/pdf/STATUTE-98-Pg1585.pdfAccessed September 28, 2015
   Google Scholar
• IMS Institute for Healthcare Informatics [webpage on the Internet]Medicines Use and Spending Shifts: A Review of the Use of Medicines in the U.S. in 20142014 Available from: http://www.imshealth.com/portal/site/imshealth/menuitem.762a961826aad98f53c753c71ad8c22a/?vgnextoid=3f140a4331e8c410VgnVCM1000000e2e2ca2RCRD&vgnextchannel=736de5fda6370410VgnVCM10000076192ca2RCRD&vgnextfmt=defaultAccessed October 3, 2015
   Google Scholar
• Generic Pharmaceutical Association [webpage on the Internet]Drug Savings in the US2014 Available from: http://www.gphaonline.org/media/cms/GPhA_Savings_Report.9.10.14_FINAL.pdfAccessed October 3, 2015
   Google Scholar
• Food and Drug Administration [webpage on the Internet]Biologics Price Competition and Innovation Act of 20092009 Available from: https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&uact=8&ved=0CB4QFjAAahUKEwja3a7IjJvIAhXIuB4KHd6hBAQ&url=http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2Fucm216146.pdf&usg=AFQjCNEbnUIJlEgV3lLOj0RZyFtHxK-1OQ&sig2=u7u-QL8P_0AFcvAiEmlvUgAccessed September 28, 2015
   Google Scholar
• Food and Drug Administration [webpage on the Internet]Filgrastimsndz2015 Available from: http://www.fda.gov/Drugs/InformationOn-Drugs/ApprovedDrugs/ucm436953.htmAccessed September 23, 2015
   Google Scholar
• Congressional Budget Office [webpage on the Internet]S. 1695, Biologics Price Competition and Innovation Act of 20072008 Available from: https://www.cbo.gov/sites/default/files/110th-congress-2007-2008/costestimate/s16950.pdfAccessed September 29, 2015
   Google Scholar
• Food and Drug Administration [webpage on the Internet]Guidance for Industry and for FDA Reviewers: Guidance on Section 216 of the Food and Drug Administration Modernization Act of 19972000 Available from: http://www.fda.gov/RegulatoryInformation/Guidances/ucm073707.htmAccessed September 28, 2015
   Google Scholar
• Navarro-SarabiaFCoronelPCollantesEA 40-month multi-centre, randomised placebo-controlled study to assess the efficacy and carry-over effect of repeated intra-articular injections of hyaluronic acid in knee osteoarthritis: the AMELIA projectAnn Rheum Dis201170111957196221852252
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration [webpage on the Internet]Premarket Approval (PMA) – GenVisc 8502015 Available from: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=10038Accessed October 3, 2015
   Google Scholar
• BraithwaiteGDaleyMJToledo-VasquezDRheological and molecular weight comparisons of approved hyaluronic acid products – preliminary standards for establishing class III medical device equivalenceJ Biomater Sci Polym Ed201627323524626569146
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration [webpage on the Internet]Summary of Safety and Effectiveness DataSUPARTZ™ Dispo – P9800442001 Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf/P980044b.pdfAccessed September 29, 2015
   Google Scholar
• XinYJianhaoLTianshengSThe efficacy and safety of sodium hyaluronate injection (Adant®) in treating degenerative osteoarthritis; a multi-center, randomized, double-blind, positive-drug parallel controlled and non-inferiority clinical studyInt J Rheum Dis201619327127826555862
   PubMed Web of Science ®Google Scholar
• CaldwellDMAdesAEHigginsJPSimultaneous comparison of multiple treatments: combining direct and indirect evidenceBMJ2005331752189790016223826
   PubMed Web of Science ®Google Scholar
• GouldALUsing prior findings to augment active-controlled trials and trials with small placebo groupsDrug Inf J1991253369380
   Google Scholar
• LunnDSpiegelhalterDThomasABestNThe BUGS project: evolution, critique and future directionsStat Med200928253049306719630097
   PubMed Web of Science ®Google Scholar
• BellamyNBuchananWWGoldsmithCHCampbellJStittLWValidation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or kneeJ Rheumatol19881512183318403068365
   PubMed Web of Science ®Google Scholar
• DayRBrooksPConaghanPGPetersenMA double blind, randomized, multicenter, parallel group study of the effectiveness and tolerance of intraarticular hyaluronan in osteoarthritis of the kneeJ Rheumatol200431477578215088306
   PubMed Web of Science ®Google Scholar
• KarlssonJSjogrenLSLohmanderLSComparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre studyRheuma-tology (Oxford)2002411112401248
   PubMed Web of Science ®Google Scholar
• LohmanderLSDalenNEnglundGIntra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multi-centre Trial GroupAnn Rheum Dis19965574244318774159
   PubMed Web of Science ®Google Scholar
• BlancoFJFernandez-SueiroJLPinto-TasendeJCIntra-articular hyaluronan treatment of patients with knee osteoarthritis waiting for replacement surgeryOpen Arthritis J20081117
   Google Scholar
• LequesneMGMeryCSamsonMGerardPIndexes of severity for osteoarthritis of the hip and knee. Validation – value in comparison with other assessment testsScand J Rheumatol Suppl19876585893479839
   PubMedGoogle Scholar
• DillonCFRaschEKGuQHirschRPrevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991-94J Rheumatol200633112271227917013996
   PubMed Web of Science ®Google Scholar
• LondonNJMillerLEBlockJEClinical and economic consequences of the treatment gap in knee osteoarthritis managementMed Hypotheses201176688789221440373
   PubMed Web of Science ®Google Scholar
• BannuruRRSchmidCHKentDMVaysbrotEEWongJBMcAlindonTEComparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysisAnn Intern Med20151621465425560713
   PubMed Web of Science ®Google Scholar
• StrandVMcIntyreLFBeachWRMillerLEBlockJESafety and efficacy of US-approved viscosupplements for knee osteoarthritis: a systematic review and meta-analysis of randomized, saline-controlled trialsJ Pain Res2015821722826005358
   PubMed Web of Science ®Google Scholar
• MillerLEBlockJEUS-approved intra-articular hyaluronic acid injections are safe and effective in patients with knee osteoarthritis: systematic review and meta-analysis of randomized, saline-controlled trialsClin Med Insights Arthritis Musculoskelet Disord20136576324027421
   PubMedGoogle Scholar
• CampbellKAEricksonBJSaltzmanBMIs local viscosupple-mentation injection clinically superior to other therapies in the treatment of osteoarthritis of the knee: a systematic review of overlapping meta-analysesArthroscopy2015311020362045.e1425998016
   PubMed Web of Science ®Google Scholar